NCT07067450 2025-07-16Adjuvant Immunotherapy for Esophageal Squamous Cell CarcinomaSichuan UniversityPhase NA Not yet recruiting98 enrolled
NCT05233358 2022-02-10HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or FailureThe Central Hospital of Lishui CityPhase NA Unknown176 enrolled